Pacira BioSciences' Other Operating Expenses fell 7754.46% to $48.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $206.6 million, marking a year-over-year decrease of 4847.59%. This contributed to the annual value of $391.0 million for FY2024, which is 6158.2% up from last year.
As of Q3 2025, Pacira BioSciences' Other Operating Expenses stood at $48.6 million, which was down 7754.46% from $55.2 million recorded in Q2 2025.
Over the past 5 years, Pacira BioSciences' Other Operating Expenses peaked at $216.4 million during Q3 2024, and registered a low of $35.2 million during Q1 2021.
Moreover, its 5-year median value for Other Operating Expenses was $55.2 million (2025), whereas its average is $65.2 million.
In the last 5 years, Pacira BioSciences' Other Operating Expenses skyrocketed by 27818.73% in 2024 and then plummeted by 7754.46% in 2025.
Over the past 5 years, Pacira BioSciences' Other Operating Expenses (Quarter) stood at $87.3 million in 2021, then grew by 2.47% to $89.5 million in 2022, then dropped by 28.16% to $64.3 million in 2023, then dropped by 15.66% to $54.2 million in 2024, then fell by 10.35% to $48.6 million in 2025.
Its Other Operating Expenses stands at $48.6 million for Q3 2025, versus $55.2 million for Q2 2025 and $48.6 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value